{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T07:09:12Z","timestamp":1793344152681,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd014861","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000}}],"reference-count":126,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd014861.pub2","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T07:12:19Z","timestamp":1745305939000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Delivery of intravenous anti-cancer therapy at home versus in hospital or community settings for adults with cancer"],"prefix":"10.1002","volume":"2025","author":[{"given":"Liesl","family":"Grobler","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine; Monash University; Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"O'Connor","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine; Monash University; Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Rischin","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology; Peter MacCallum Cancer Centre; Melbourne Australia"},{"name":"The Sir Peter MacCallum Department of Oncology; University of Melbourne; Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polina","family":"Putrik","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine; Monash University; Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Karnon","sequence":"additional","affiliation":[{"name":"Flinders Health and Medical Research Institute, College of Medicine and Public Health; Flinders University; Adelaide Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kobi J","family":"Rischin","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine; Monash University; Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayden J","family":"McKenzie","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine; Monash University; Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noa","family":"Ben Ami","sequence":"additional","affiliation":[{"name":"Department of Physical Therapy; Ariel University; Ariel Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhiannon","family":"Whale","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine; Monash University; Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachelle","family":"Buchbinder","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine; Monash University; Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"issue":"7290","key":"10.1002\/14651858.CD014861.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1136\/bmj.322.7290.826","article-title":"Compliance, satisfaction, and quality of life of patients with colorectal cancer receiving home chemotherapy or outpatient treatment: a randomised controlled trial","volume":"322","author":"Borras","year":"2001","journal-title":"BMJ"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD014861.pub2-BIB0002|cit2","first-page":"163","article-title":"Home chemotherapy in oncology: results from a phase III\/IV clinical trial","volume":"1 Suppl 1","author":"Navarro","year":"1999","journal-title":"Revista de Oncologia"},{"issue":"6","key":"10.1002\/14651858.CD014861.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1038\/bjc.2013.414","article-title":"Is community treatment best? A randomised trial comparing delivery of cancer treatment in the hospital, home and GP surgery","volume":"109","author":"Corrie","year":"2013","journal-title":"British Journal of Cancer"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1186\/1471-2407-11-467","article-title":"Protocol for the OUTREACH trial: a randomised trial comparing delivery of cancer systemic therapy in three different settings: patient's home, GP surgery and hospital day unit","volume":"11","author":"Corrie","year":"2011","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1002\/14651858.CD014861.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.7748\/cnp2008.02.7.1.35.c6469","article-title":"Evaluating patients\u2019 experiences of home and hospital chemotherapy","volume":"7","author":"Hall","year":"2008","journal-title":"Cancer Nursing Practice"},{"issue":"3","key":"10.1002\/14651858.CD014861.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2190\/CY03-EV15-K38Y-X4AA","article-title":"Home or hospital? An evaluation of the costs, preferences, and outcomes of domiciliary chemotherapy","volume":"30","author":"King","year":"2000","journal-title":"International Journal of Health Services"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"S294","DOI":"10.1016\/S0959-8049%2811%2971317-X","article-title":"A randomised crossover trial to determine safety, quality of life and economic consequences of home-based chemotherapy","volume":"47 Suppl 1","author":"Christiansen","year":"2011","journal-title":"European Journal of Cancer"},{"issue":"5","key":"10.1002\/14651858.CD014861.pub2-BIB0008|cit8","first-page":"A5482","article-title":"Safety and feasibility of home-based chemotherapy","volume":"65","author":"Larsen","year":"2018","journal-title":"Danish Medical Journal"},{"issue":"6","key":"10.1002\/14651858.CD014861.pub2-BIB0009|cit9","first-page":"649","article-title":"Developing home-care hospitalization: cost evaluation and assessment criteria. The case of anticancer chemotherapy","volume":"51","author":"Remonnay","year":"2003","journal-title":"Revue d'Epidemiologie et de Sante Publique"},{"issue":"3","key":"10.1002\/14651858.CD014861.pub2-BIB0010|cit10","first-page":"508","article-title":"Economic evaluation of anti-neoplasic chemotherapy administered at home or in hospitals","volume":"18","author":"Remonnay","year":"2002","journal-title":"International Journal of Technology Assessment in Health Care"},{"issue":"3","key":"10.1002\/14651858.CD014861.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5694\/j.1326-5377.2000.tb125563.x","article-title":"A randomised crossover trial of chemotherapy in the home: patient preferences and cost analysis","volume":"173","author":"Rischin","year":"2000","journal-title":"Medical Journal of Australia"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0012|cit12","unstructured":"White M Rischin D Matthews J Watty K Sulkowski A Toner G A randomised crossover trial of chemotherapy administered in the hospital versus the home Clinical Oncological Society of Australia (COSA), 26th Annual Scientific Meeting 1999"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0013|cit13","unstructured":"Pilot study to look at the feasibility of using remote vital sign monitoring app to improve the care of patients being treated at home with highly myelosuppressive chemotherapy https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=366657&isReview=true"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0014|cit14","unstructured":"A randomised controlled trial of breast cancer patients treated with chemotherapy in a hospital day unit or at home: an analysis of cost and patient reported outcomes https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=367891&isReview=true"},{"issue":"10 Suppl","key":"10.1002\/14651858.CD014861.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1016\/j.clml.2019.09.577","article-title":"Introducing self administration of bortezomib (velcade) to myeloma patients","volume":"19","author":"Burton","year":"2019","journal-title":"Clinical Lymphoma, Myeloma & Leukemia"},{"issue":"6","key":"10.1002\/14651858.CD014861.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"312","DOI":"10.5694\/j.1326-5377.2001.tb143292.x","article-title":"A randomised crossover trial of chemotherapy in the home: patient preferences and cost analysis","volume":"174","author":"Bydder","year":"2001","journal-title":"Medical Journal of Australia"},{"issue":"5","key":"10.1002\/14651858.CD014861.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/NHH.0000000000000231","article-title":"Safe chemotherapy in the home environment","volume":"33","author":"Chavis-Parker","year":"2015","journal-title":"Home Healthcare Now"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"v565","DOI":"10.1093\/annonc\/mdx388.067","article-title":"Oncological home-hospitalization: prospective randomized trial to evaluate its implications for patient and society","volume":"28 Suppl 5","author":"Cool","year":"2017","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1200\/GO.21.00158","article-title":"Oncologic home-hospitalization delivers a high-quality and patient-centered alternative to standard ambulatory care: results of a randomized-controlled equivalence trial","volume":"7","author":"Cool","year":"2021","journal-title":"JCO Global Oncology"},{"issue":"1","key":"10.1002\/14651858.CD014861.pub2-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13690-024-01317-1","article-title":"Onco@home: comparing the costs and reimbursement of cancer treatment at home with the standard of care","volume":"82","author":"Misplon","year":"2024","journal-title":"Archives of Public Health [Archives Belges de Sante Publique]"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0021|cit21","unstructured":"Evaluating quality and cost of (partial) oncological home-hospitalization ClinicalTrials.gov"},{"issue":"6","key":"10.1002\/14651858.CD014861.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1177\/1078155219891566","article-title":"Impact of transitioning inpatient chemotherapy regimens to the outpatient setting","volume":"26","author":"Corsi","year":"2020","journal-title":"Journal of Oncology Pharmacy Practice"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10549-020-05604-7","article-title":"Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer","volume":"181","author":"Denys","year":"2020","journal-title":"Breast Cancer Research and Treatment"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0024|cit24","unstructured":"A study of subcutaneous at home administration of trastuzumab (Herceptin) in participants with human epidermal growth factor receptor 2-positive (HER2+) early breast cancer (EBC) https:\/\/ClinicalTrials.gov\/show\/NCT01926886"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0025|cit25","unstructured":"Home delivery of pemetrexed : a feasibility study European Union Clinical Trial Register; https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2011-000841-19\/GB"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0026|cit26","unstructured":"A study to investigate subcutaneous trastuzumab administration at home with a Single Injection Device in patients with HER2-positive early breast cancer European Union Clinical Trial Register; https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2013-000829-31\/NL"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.breast.2020.05.001","article-title":"Hospital-based or home-based administration of oncology drugs? A micro-costing study comparing healthcare and societal costs of hospital-based and home-based subcutaneous administration of trastuzumab","volume":"52","author":"Franken","year":"2020","journal-title":"Breast (Edinburgh, Scotland)"},{"issue":"27","key":"10.1002\/14651858.CD014861.pub2-BIB0028|cit28","first-page":"1055","article-title":"Oncologic therapy at home: a trial model","volume":"114","author":"Frohmuller","year":"1989","journal-title":"Onkologische Therapie zu Hause. Ein Modellversuch"},{"issue":"2","key":"10.1002\/14651858.CD014861.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.anai.2017.11.002","article-title":"Home-based subcutaneous immunoglobulin therapy vs hospital-based intravenous immunoglobulin therapy: a prospective economic analysis","volume":"120","author":"Fu","year":"2018","journal-title":"Annals of Allergy, Asthma & Immunology"},{"issue":"5","key":"10.1002\/14651858.CD014861.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7748\/cnp.2018.e1474","article-title":"Exploring the benefits of a home pembrolizumab infusion service for patients with advanced melanoma","volume":"17","author":"Gifford","year":"2018","journal-title":"Cancer Nursing Practice"},{"issue":"1","key":"10.1002\/14651858.CD014861.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0022-5347(01)66527-3","article-title":"Interleukin-2 based home therapy of metastatic renal cell carcinoma: risks and benefits in 215 consecutive single institution patients","volume":"155","author":"Hanninen","year":"1996","journal-title":"Journal of Urology"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0032|cit32","unstructured":"Hirtzlin I Pre\u0301aubert-Hayes N In-hospital and at-home cancer chemotherapy: a comparison ofcosts and organisation of care https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/chimio_eco_gb.pdf"},{"issue":"8","key":"10.1002\/14651858.CD014861.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"100072","DOI":"10.1016\/j.apjon.2022.04.011","article-title":"\"It's a part of the patient\": The experiences of patients with cancer undergoing home-based chemotherapy from patients' and nurses' perspectives","volume":"9","author":"Jang","year":"2022","journal-title":"Asia-Pacific Journal of Oncology Nursing"},{"issue":"7","key":"10.1002\/14651858.CD014861.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00520-010-0917-7","article-title":"Economic and patient-reported outcomes of outpatient home-based versus inpatient hospital-based chemotherapy for patients with colorectal cancer","volume":"19","author":"Joo","year":"2011","journal-title":"Supportive Care in Cancer"},{"issue":"6","key":"10.1002\/14651858.CD014861.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"312","DOI":"10.5694\/j.1326-5377.2001.tb143291.x","article-title":"A randomised crossover trial of chemotherapy in the home: patient preferences and cost analysis (multiple letters)","volume":"174","author":"King","year":"2001","journal-title":"Medical Journal of Australia"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0036|cit36","first-page":"305","article-title":"Trial of home infusion therapy for near-terminal stage patients with lung cancer","volume":"23 Suppl 3","author":"Kozaki","year":"1996","journal-title":"Gan to Kagaku Ryoho. Cancer & Chemotherapy"},{"issue":"3","key":"10.1002\/14651858.CD014861.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/cam4.3690","article-title":"Home-based chemotherapy for stage III colon cancer patients in Thailand: cost-utility and budget impact analyses","volume":"10","author":"Kulthanachairojana","year":"2021","journal-title":"Cancer Medicine"},{"issue":"2","key":"10.1002\/14651858.CD014861.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/annonc\/mdv563","article-title":"Home administration of bortezomib in multiple myeloma is cost-effective and is preferred by patients compared with hospital administration: results of a prospective single-center study","volume":"27","author":"Lassalle","year":"2016","journal-title":"Annals of Oncology"},{"issue":"6","key":"10.1002\/14651858.CD014861.pub2-BIB0039|cit39","first-page":"1613","article-title":"Home-based zoledronic acid (ZOL) infusion therapy in patients with solid tumours: compliance and patient-nurse satisfaction","volume":"21","author":"Lebret","year":"2013","journal-title":"Annals of Oncology"},{"issue":"4","key":"10.1002\/14651858.CD014861.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"184","DOI":"10.5694\/j.1326-5377.1996.tb124921.x","article-title":"Home chemotherapy for cancer patients: cost analysis and safety","volume":"165","author":"Lowenthal","year":"1996","journal-title":"Medical Journal of Australia"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0041|cit41","first-page":"260, Abstract 1","article-title":"Hospital inpatient vs home chemotherapy for patients with head and neck cancer","volume":"6","author":"Magid","year":"1987","journal-title":"Proceedings of the American Society of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD014861.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/sct.1989.5.137","article-title":"A randomized study of inpatient versus outpatient continuous intravenous infusion chemotherapy: psychosocial aspects","volume":"5","author":"Magid","year":"1989","journal-title":"Selective Cancer Therapeutics"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/1097-0142(19890101)63:1<30::AID-CNCR2820630105>3.0.CO;2-M","article-title":"A randomized study of inpatient versus outpatient continuous infusion chemotherapy for patients with locally advanced head and neck cancer","volume":"63","author":"Vokes","year":"1989","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/1097-0142(19890915)64:6<1375::AID-CNCR2820640634>3.0.CO;2-6","article-title":"A randomized clinical trial of home nursing care for lung cancer patients","volume":"64","author":"McCorkle","year":"1989","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0045|cit45","first-page":"138","article-title":"The time spent at home by patients receiving palliative chemotherapy for head and neck cancer","volume":"9","author":"Morton","year":"1984","journal-title":"Clinical Otolaryngology"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1016\/j.jval.2020.04.587","article-title":"Pmd19 systematic literature review to identify the current state of knowledge regarding home infusion vs medical-setting infusion","volume":"23 Suppl 1","author":"Myers","year":"2020","journal-title":"Value in Health"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0047|cit47","unstructured":"Feasibility of immunotherapy administration to patients with bronchial cancer in a hospital-at home setting (ImHADom) ClinicalTrials.gov; https:\/\/clinicaltrials.gov\/study\/NCT03786653?cond=NCT03786653&rank=1"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0048|cit48","unstructured":"Feasibility of immunotherapy plus chemotherapy administration to patients with bronchial cancer in a hospital-at home setting ClinicalTrials.gov; https:\/\/clinicaltrials.gov\/study\/NCT04802902?cond=NCT04802902&rank=1"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0049|cit49","unstructured":"Feasiblity and safety of home-based intensive chemotherapy ClinicalTrials.gov; https:\/\/clinicaltrials.gov\/study\/NCT04904211?cond=NCT04904211&rank=1"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0050|cit50","unstructured":"Secure outsourcing of carfilzomib in the treatment of multiple myeloma to the hospital at home setting ClinicalTrials.gov; https:\/\/clinicaltrials.gov\/study\/NCT05041933?cond=NCT04904211&rank=1"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0051|cit51","unstructured":"Perspectives of subcutaneous velcade at home of patients with myeloma ClinicalTrials.gov; https:\/\/clinicaltrials.gov\/study\/NCT05163405?cond=NCT04904211&rank=1"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0052|cit52","unstructured":"Trial to test feasibility of at-home immunotherapy administration https:\/\/www.healio.com\/news\/hematology-oncology\/20240513\/trial-to-test-feasibility-of-athome-immunotherapy-administration"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0053|cit53","unstructured":"Subcutaneous atezolizumab for the treatment of non-small cell lung cancer https:\/\/clinicaltrials.gov\/study\/NCT05340309"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0054|cit54","unstructured":"Comparison of in-home versus in-clinic administration of subcutaneous nivolumab through cancer CARE (connected access and remote expertise) beyond walls (CCBW) program Clinicaltrials.gov; https:\/\/clinicaltrials.gov\/study\/NCT06265285"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0055|cit55","unstructured":"COVID-19 rapid guideline: delivery of systemic anticancer treatments National Institute for Health and Care Excellence (NICE) Guideline 2021; https:\/\/www.nice.org.uk\/guidance\/ng161"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"106756. doi: 10","DOI":"10.1016\/j.leukres.2021.106756","article-title":"A national Danish proof of concept on feasibility and safety of home -based intensive chemotherapy in patients with acute myeloid leukemia","volume":"112","author":"N\u00f8rskov","year":"2022","journal-title":"Leukemia Research"},{"issue":"2","key":"10.1002\/14651858.CD014861.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2354.2008.01051.x","article-title":"Chemotherapy in the community: what do patients want?","volume":"18","author":"Pace","year":"2009","journal-title":"European Journal of Cancer Care"},{"issue":"7","key":"10.1002\/14651858.CD014861.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.jaip.2020.05.007","article-title":"Health and economic outcomes of home maintenance allergen immunotherapy in select patients with high health literacy during the COVID-19 pandemic: a cost-effectiveness analysis during exceptional times","volume":"8","author":"Shaker","year":"2020","journal-title":"Journal of Allergy and Clinical Immunology. In Practice"},{"issue":"6","key":"10.1002\/14651858.CD014861.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1002\/nop2.1016","article-title":"Evaluation of adverse events and health-related quality of life in patients with colorectal cancer receiving ambulatory home-based chemotherapy in Thailand","volume":"8","author":"Sirilerttrakul","year":"2021","journal-title":"Nursing Open"},{"issue":"3","key":"10.1002\/14651858.CD014861.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"144","DOI":"10.12968\/ijpn.2004.10.3.12602","article-title":"Home care versus hospital care in patients with multiple myeloma treated with pamidronate","volume":"10","author":"Smith","year":"2004","journal-title":"International Journal of Palliative Nursing"},{"issue":"4","key":"10.1002\/14651858.CD014861.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10198-021-01278-0","article-title":"The cost of chemotherapy administration: a systematic review and meta-analysis","volume":"22","author":"Sohi","year":"2021","journal-title":"European Journal of Health Economics: HEPAC : Health Economics in Prevention and Care"},{"issue":"8 Supplement 1","key":"10.1002\/14651858.CD014861.pub2-BIB0062|cit62","first-page":"43","article-title":"The administration of immuno-oncology agents in UK clinical practice: exploration of the patient benefits derived from the home-infusion service","volume":"23","author":"Stoner","year":"2017","journal-title":"Journal of Oncology Pharmacy Practice"},{"issue":"8","key":"10.1002\/14651858.CD014861.pub2-BIB0063|cit63","first-page":"115","article-title":"Application of home-based self-care interventions for lung cancer patients with peripheral inserted central catheter during the intermission of chemotherapy","volume":"4","author":"Sun","year":"2018","journal-title":"Nursing of Integrated Traditional Chinese & Western Medicine"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0064|cit64","doi-asserted-by":"crossref","unstructured":"Sirilerttrakul S Wannakansophon N Utthiya P Ckumdee S Tangteerakoon P Chansriwong P Evaluation of adverse events and health-related quality of life in patients with colorectal cancer receiving ambulatory home-based chemotherapy in Thailand Nursing Open 2021 8 6 3036 44 10.1002\/nop2.1016","DOI":"10.1002\/nop2.1016"},{"issue":"12","key":"10.1002\/14651858.CD014861.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1007\/s00520-016-3363-3","article-title":"Cost savings of home bortezomib injection in patients with multiple myeloma treated by a combination care in outpatient hospital and hospital care at home","volume":"24","author":"Touati","year":"2016","journal-title":"Supportive Care in Cancer"},{"issue":"4","key":"10.1002\/14651858.CD014861.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.aenj.2007.09.070","article-title":"Does peripheral intravenous catheter dwell time effect the development of phlebitis? A randomised control [sic] trial in home-based acute care. 6th International Conference for Emergency Nurses: Future Directions, Future ChallengesEL Beyond Tomorrow, 11-13 October 2007, Melbourne, Victoria, Australia","volume":"10","author":"Van Donk","year":"2007","journal-title":"Australasian Emergency Nursing Journal"},{"issue":"3 Pt 1","key":"10.1002\/14651858.CD014861.pub2-BIB0067|cit67","first-page":"255","article-title":"Economic analysis of home based versus hospital outpatient chemotherapy in stage IV non small cell lung cancer","volume":"23","author":"Vergnenegre","year":"2006","journal-title":"Revue des Maladies Respiratoires"},{"issue":"1","key":"10.1002\/14651858.CD014861.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"100007","DOI":"10.1016\/j.esmoop.2020.100007","article-title":"Flexible care in breast cancer","volume":"6","author":"Wardley","year":"2021","journal-title":"ESMO Open"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0069|cit69","first-page":"S104","article-title":"Evaluating a shared care model designed to improve supportive care for patients receiving outpatient chemotherapy","volume":"29 Suppl 1","author":"White","year":"2021","journal-title":"Supportive Care in Cancer"},{"issue":"4","key":"10.1002\/14651858.CD014861.pub2-BIB0070|cit70","first-page":"533","article-title":"Outpatient chemotherapy for lung cancer","volume":"34","author":"Yoneda","year":"2007","journal-title":"Gan to Kagaku Ryoho. Cancer & Chemotherapy"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0071|cit71","unstructured":"Caleo S King M Cameron S Hall J An evaluation of domiciliary chemotherapy Clinical Oncological Society of Australia (COSA), 23rd Annual Scientific Meeting 1996"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0072|cit72","unstructured":"Cunningham D Norman A Iveson T Oates J Iveson A Bett N Adjuvant chemotherapy colorectal cancer a prospective randomised evaluation of standard chemotherapy compared to home chemotherapy with an analysis of health care costs & quality of life Scientific Basis of Health Services International Conference 1995"},{"issue":"1 Supplement","key":"10.1002\/14651858.CD014861.pub2-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"B046","DOI":"10.1158\/1538-7755.DISP22-B046","article-title":"Feasibility of patient-centered home care (PCHC) to reduce disparities in Black men (BM) with advanced prostate cancer (CaP): An iCCaRE Consortium for prostate cancer in Black men project","volume":"32","author":"Dronca","year":"2023","journal-title":"Cancer Epidemiology Biomarkers and Prevention"},{"issue":"Supplement 186","key":"10.1002\/14651858.CD014861.pub2-BIB0074|cit74","first-page":"http:\/\/dx.doi.o","article-title":"Cost minimization analysis of treatment with subcutaneous trastuzumab in outpatient ward vs alternation of outpatient ward and at home in patients with HER2-positive breast cancer","volume":"73","author":"Grouvvel","year":"2019","journal-title":"International Journal of Clinical Practice"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0075|cit75","unstructured":"Grusenmeyer PA Gralla RJ Trapani MM Bateman MM Alternatives to inpatient care: a cost comparison of home versus outpatient clinic care for chemotherapy administration and supportive care measures Proceedings of the American Society of Clinical Oncology 1996"},{"issue":"6","key":"10.1002\/14651858.CD014861.pub2-BIB0076|cit76","first-page":"649","article-title":"Developing home-care hospitalization: cost evaluation and assessment criteria. The case of anticancer chemotherapy","volume":"51","author":"Remonnay","year":"2003","journal-title":"Revue d'Epidemiologie et de Sante Publique"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0077|cit77","first-page":"117","article-title":"Differences in the patient anxiety, quality of life (QOL) and nursing efficacy at the first course of chemotherapy infused at home and in hospital","volume":"9 Suppl 1","author":"Chen","year":"1999","journal-title":"International Journal of Gynecological Cancer"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0078|cit78","unstructured":"Carvalho de Freitas A Feugier P Cost-utility analysis of home-based versus hospital-based chemotherapy in multiple myeloma: case of carfilzomib https:\/\/ClinicalTrials.gov\/show\/NCT05184595"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0079|cit79","unstructured":"Cost-utility analysis of home-based versus hospital-based chemotherapy in multiple myeloma: case of carfilzomib ClinicalTrials.gov; https:\/\/clinicaltrials.gov\/search?cond=NCT05184595"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0080|cit80","unstructured":"Clinical trial\/study for breast cancer patient with HER2 positive Clinical Trials Registry-India; https:\/\/ctri.nic.in\/Clinicaltrials\/pmaindet2.php?EncHid=NzIyNzk=&Enc=&userName="},{"key":"10.1002\/14651858.CD014861.pub2-BIB0081|cit81","unstructured":"A clinical trial to look at patients preference of home dosing with a fixed-dose combination of pertuzumab and trastuzumab in people with early or locally advanced Her2-positive breast cancer European Union Clinical Trials Register; https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/search?query=EUCTR2021-002346-33-ES"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0082|cit82","unstructured":"A study to evaluate patient preference for home administration of fixed-dose combination of pertuzumab and trastuzumab for subcutaneous administration in participants with early or locally advanced\/inflammatory HER2-positive breast cancer ClinicalTrials.gov; https:\/\/clinicaltrials.gov\/study\/NCT05415215?cond=NCT05415215&rank=1"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0083|cit83","unstructured":"A study to evaluate patient preference for home administration of fixed-dose combination of pertuzumab and trastuzumab for subcutaneous administration in participants with early or locally advanced\/inflammatory HER2-positive breast cancer (ProHer) Pan African Clinical Trials Registry; https:\/\/pactr.samrc.ac.za\/TrialDisplay.aspx?TrialID=24100"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0084|cit84","unstructured":"At-home cancer directed therapy versus in clinic for the treatment of patients with advanced cancer, cancer care beyond walls ClinicalTrials.gov; https:\/\/clinicaltrials.gov\/study\/NCT05969860?cond=NCT05415215&rank=1"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0085|cit85","first-page":"S138","article-title":"Interim analysis of a study to investigate safety, quality of life (QOL), patient satisfaction & preference with domiciliary versus day ward administration of bortezomib","volume":"96 Suppl 1","author":"Ryman","year":"2011","journal-title":"Haematologica"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0086|cit86","unstructured":"Australian Institute of Health and Welfare Health system expenditure on cancer and other neoplasms in Australia, 2015\u201316; March 2021 Available from: www.aihw.gov.au\/reports\/cancer\/health-system-expenditure-cancer-other-neoplasms\/summary (accessed 12 November 2024)"},{"issue":"6","key":"10.1002\/14651858.CD014861.pub2-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0088|cit88","unstructured":"How to write a plain language summary of a Cochrane intervention review; 2019 www.cochrane.no\/sites\/cochrane.no\/files\/public\/uploads\/how_to_write_a_cochrane_pls_12th_february_2019.pdf"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.critrevonc.2018.03.011","article-title":"Organization, quality and cost of oncological home-hospitalization: a systematic review","volume":"126","author":"Cool","year":"2018","journal-title":"Critical Reviews in Oncology\/hematology"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0090|cit90","doi-asserted-by":"crossref","unstructured":"Corbett M Heirs M Rose M Smith A Stirk L Richardson G The delivery of chemotherapy at home: an evidence synthesis; Health Services and Delivery Research, No. 3.14 ; 2015 Available from: www.ncbi.nlm.nih.gov\/books\/NBK285513\/?report=printable; accessed 12 November 2024","DOI":"10.3310\/hsdr03140"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0091|cit91","unstructured":"Covidence Veritas Health Innovation 2025"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0092|cit92","unstructured":"Deeks JJ Higgins JP Altman DG McKenzie JE Veroniki AA Chapter 10: Analysing data and undertaking meta-analyses (last updated November 2024). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024 Available from https:\/\/training.cochrane.org\/handbook\/current\/chapter-10"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0093|cit93","unstructured":"EndNote The EndNote Team Clarivate 2013"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0094|cit94","unstructured":"Suggested risk of bias criteria for EPOC reviews. EPOC resources for review authors; 2013 Available from: epoc.cochrane.org\/epoc-specific-resources-review-authors"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0095|cit95","unstructured":"EPPI-Center. CCEMG - EPPI-Centre Cost Converter eppi.ioe.ac.uk\/costconversion\/default.aspx"},{"issue":"5","key":"10.1002\/14651858.CD014861.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/ecc.12408","article-title":"A multi-method review of home-based chemotherapy","volume":"25","author":"Evans","year":"2016","journal-title":"European Journal of Cancer Care"},{"issue":"2","key":"10.1002\/14651858.CD014861.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1017\/S0266462305050324","article-title":"Criteria list for assessment of methodological quality of economic evaluations: consensus on Health Economic Criteria","volume":"21","author":"Evers","year":"2005","journal-title":"International Journal of Technology Assessment in Health Care"},{"issue":"7","key":"10.1002\/14651858.CD014861.pub2-BIB0098|cit98","doi-asserted-by":"publisher","first-page":"e0201552","DOI":"10.1371\/journal","article-title":"Health services costs for cancer care in Australia: estimates from the 45 and Up Study","volume":"13","author":"Goldsbury","year":"2018","journal-title":"PloS One"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0099|cit99","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2024"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ageing\/11.2.121","article-title":"Measuring behavioural disturbance of elderly demented patients in the community and its effects on relatives: a factor analytic study","volume":"11","author":"Greene","year":"1982","journal-title":"Age and Ageing"},{"issue":"7650","key":"10.1002\/14651858.CD014861.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0103|cit103","unstructured":"Higgins JP Altman DG Sterne JA Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from: https:\/\/training.cochrane.org\/handbook\/archive\/v5.1\/"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0104|cit104","unstructured":"Higgins JP Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect (last updated August 2023). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024 Available from https:\/\/training.cochrane.org\/handbook\/current\/chapter-06"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0105|cit105","unstructured":"Higgins JP Eldridge S Li T Chapter 23: Including variants on randomized trials (last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024 Available from https:\/\/training.cochrane.org\/handbook\/current\/chapter-23"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0106|cit106","unstructured":"Hirtzlin I on behalf of Haute Autorit\u00e9 de sant\u00e9 (HAS) \u2013 Health Economics and Public HealthDepartment In-hospital and at-home cancer chemotherapy: a comparison of costs and organisation of care https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/chimio_eco_gb.pdf"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"g1687","DOI":"10.1136\/bmj.g1687","article-title":"Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide","volume":"348","author":"Hoffmann","year":"2014","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD014861.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jval.2013.02.002","article-title":"Consolidated health economic evaluation reporting standards (CHEERS)-explanation and elaboration: a report of the ISPOR health economic evaluations publication guidelines good reporting practices task force","volume":"16","author":"Husereau","year":"2013","journal-title":"Value in Health"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0109|cit109","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated October 2023). Cochrane, 2023 Available from https:\/\/training.cochrane.org\/handbook\/archive\/v6.4\/chapter-04"},{"issue":"7","key":"10.1002\/14651858.CD014861.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Medicine"},{"issue":"2","key":"10.1002\/14651858.CD014861.pub2-BIB0111|cit111","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/jnci\/djq495","article-title":"Projections of the cost of cancer care in the United States: 2010-2020","volume":"103","author":"Mariotto","year":"2011","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/00005650-198405000-00011","article-title":"Development of scales to measure satisfaction and preferences regarding long-term and terminal care","volume":"22","author":"McCusker","year":"1984","journal-title":"Medical Care"},{"issue":"10","key":"10.1002\/14651858.CD014861.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.1007\/s00520-021-06145-5","article-title":"Impacts on health outcomes and on resources utilization for anticancer drugs injection at home, a complex intervention: a systematic review","volume":"29","author":"Mittaine-Marzac","year":"2021","journal-title":"Supportive Care in Cancer"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0114|cit114","first-page":"S191","article-title":"Systematic literature review to identify the current state of knowledge regarding home infusion vs medical-setting infusion","volume":"23 Suppl 1","author":"Smolen","year":"2020","journal-title":"Value in Health"},{"issue":"2","key":"10.1002\/14651858.CD014861.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2354.2008.01051.x","article-title":"Chemotherapy in the community: what do patients want?","volume":"18","author":"Pace","year":"2009","journal-title":"European Journal of Cancer Care"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0116|cit116","doi-asserted-by":"publisher","first-page":"46958019880696","DOI":"10.1177\/0046958019880696","article-title":"Health care expenditure burden of cancer care in the United States","volume":"56","author":"Park","year":"2019","journal-title":"Inquiry"},{"issue":"2","key":"10.1002\/14651858.CD014861.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"e000285","DOI":"10.1136\/esmoopen-2017-000285","article-title":"Global cancer control: responding to the growing burden, rising costs and inequalities in access","volume":"3","author":"Prager","year":"2018","journal-title":"ESMO Open"},{"issue":"4","key":"10.1002\/14651858.CD014861.pub2-BIB0118|cit118","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1071\/AH20160","article-title":"Prioritising models of healthcare service delivery for a more sustainable health system: a Delphi study of Australian health policy, clinical practice and management, academic and consumer stakeholders","volume":"45","author":"Putrik","year":"2021","journal-title":"Australian Health Review"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0119|cit119","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2025"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0120|cit120","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence (last updated August 2023). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024 Available from https:\/\/training.cochrane.org\/handbook\/current\/chapter-14"},{"issue":"3","key":"10.1002\/14651858.CD014861.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"144","DOI":"10.12968\/ijpn.2004.10.3.12602","article-title":"Home care versus hospital care in patients with multiple myeloma treated with pamidronate","volume":"10","author":"Smith","year":"2004","journal-title":"International Journal of Palliative Nursing"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0122|cit122","volume-title":"Statistical Brief (Medical Expenditure Panel Survey (US))","author":"Soni","year":"2014"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0123|cit123","doi-asserted-by":"publisher","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD014861.pub2-BIB0124|cit124","unstructured":"American Cancer Society the International Agency for Research on Cancer and the Union for International Cancer Control The Cancer Atlas: The Economic Burden of Cancer www.canceratlas.cancer.org\/taking-action\/economic-burden\/"},{"issue":"1","key":"10.1002\/14651858.CD014861.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"100007","DOI":"10.1016\/j.esmoop.2020.100007","article-title":"Flexible care in breast cancer","volume":"6","author":"Wardley","year":"2021","journal-title":"ESMO Open"},{"issue":"5","key":"10.1002\/14651858.CD014861.pub2-BIB0126|cit126","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD014861","article-title":"Delivery of intravenous anti-cancer therapy at home versus in hospital or community settings for adults with cancer","author":"Grobler","year":"2022","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T06:32:35Z","timestamp":1785738755000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD014861.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":126,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd014861.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,22]]}}}